Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 8597085, 5 pages
http://dx.doi.org/10.1155/2016/8597085
Research Article

The Association of Peroxisome Proliferator-Activated Receptor δ and Additional Gene-Gene Interaction with C-Reactive Protein in Chinese Population

1Department of Anesthesia, The Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi 710004, China
2Department of Anesthesia, The First Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China
3The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, Shaanxi 710049, China
4Department of Pediatric Surgery, The Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi 710004, China

Received 24 September 2015; Accepted 8 December 2015

Academic Editor: Francesco Perticone

Copyright © 2016 Xiao-Ying Ding et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Shoelson and A. B. Goldfine, “Getting away from glucose: fanning the flames of obesity-induced inflammation,” Nature Medicine, vol. 15, no. 4, pp. 373–374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” The New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. T. B. Ledue and N. Rifai, “Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment,” Clinical Chemistry, vol. 49, no. 8, pp. 1258–1271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Bookout, Y. Jeong, M. Downes, R. T. Yu, R. M. Evans, and D. J. Mangelsdorf, “Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network,” Cell, vol. 126, no. 4, pp. 789–799, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Michalik, J. Auwerx, J. P. Berger et al., “International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors,” Pharmacological Reviews, vol. 58, no. 4, pp. 726–741, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Guo and R. Tabrizchi, “Peroxisome proliferator-activated receptor γ as a drug target in the pathogenesis of insulin resistance,” Pharmacology and Therapeutics, vol. 111, no. 1, pp. 145–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Michalik, B. Desvergne, C. Dreyer, M. Gavillet, R. N. Laurini, and W. Wahli, “PPAR expression and function during vertebrate development,” International Journal of Developmental Biology, vol. 46, no. 1, pp. 105–114, 2002. View at Google Scholar · View at Scopus
  8. C.-H. Lee, A. Chawla, N. Urbiztondo, D. Liao, W. A. Boisvert, and R. M. Evans, “Transcriptional repression of atherogenic inflammation: modulation by PPARδ,” Science, vol. 302, no. 5644, pp. 453–457, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Vosper, L. Patel, T. L. Graham et al., “The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages,” The Journal of Biological Chemistry, vol. 276, no. 47, pp. 44258–44265, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. W. R. Oliver Jr., J. L. Shenk, M. R. Snaith et al., “A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5306–5311, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Iida, J. V. Kumar, D. T. Kopycka-Kedzierawski, and R. J. Billings, “Effect of tobacco smoke on the oral health of US women of childbearing age,” Journal of Public Health Dentistry, vol. 69, no. 4, pp. 231–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Freiberg, H. J. Cabral, T. C. Heeren, R. S. Vasan, and R. C. Ellison, “Alcohol consumption and the prevalence of the metabolic syndrome in the US,” Diabetes Care, vol. 27, no. 12, pp. 2954–2959, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Hu, J. Tuomilehto, K. Silventoinen, N. Barengo, and P. Jousilahti, “Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women,” European Heart Journal, vol. 25, no. 24, pp. 2212–2219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. X.-Y. Lou, G.-B. Chen, L. Yan et al., “A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence,” The American Journal of Human Genetics, vol. 80, no. 6, pp. 1125–1137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. X. J. Yu, B. L. Su, X. M. Wang, C. J. Jin, J. M. Qu, and H. J. Feng, “The relationship of some indices of glycometabolism with peroxisome proliferator-activated receptor delta polymorphism,” Chinese Journal of Diabetes, vol. 15, no. 10, pp. 596–597, 2007. View at Google Scholar
  16. H. D. Shin, B. L. Park, L. H. Kim et al., “Genetic polymorphisms in peroxisome proliferator-activated receptor δ associated with obesity,” Diabetes, vol. 53, no. 3, pp. 847–851, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Skogsberg, K. Kannisto, T. N. Cassel, A. Hamsten, P. Eriksson, and E. Ehrenborg, “Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 4, pp. 637–643, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Skogsberg, A. D. McMahon, F. Karpe, A. Hamsten, C. J. Packard, and E. Ehrenborg, “Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men,” Journal of Internal Medicine, vol. 254, no. 6, pp. 597–604, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. P. M. Ridker, “C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus,” Journal of the American College of Cardiology, vol. 49, no. 21, pp. 2129–2138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Yang, C.-H. Chu, P.-C. Hsieh et al., “C-reactive protein concentration as a significant correlate formetabolic syndrome: a Chinese population-based study,” Endocrine, vol. 43, no. 2, pp. 351–359, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Gelaye, L. Revilla, T. Lopez et al., “Association between insulin resistance and C-reactive protein among Peruvian adults,” Diabetology and Metabolic Syndrome, vol. 2, no. 1, article 30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. J. MacGregor, J. R. Gallimore, T. D. Spector, and M. B. Pepys, “Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins,” Clinical Chemistry, vol. 50, no. 1, pp. 130–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-J. Gu, D.-H. Chen, Z.-R. Guo, Z.-Y. Zhou, X.-S. Hu, and M. Wu, “Effect of obesity on the association between common variations in the PPAR gene and C-reactive protein level in Chinese Han population,” Endocrine, vol. 48, no. 1, pp. 195–202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-J. Liang, Y.-C. Liu, C.-Y. Chen et al., “Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells,” International Journal of Cardiology, vol. 143, no. 3, pp. 361–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Ravaux, C. Denoyelle, C. Monne, I. Limon, M. Raymondjean, and K. El Hadri, “Inhibition of interleukin-1β-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator- activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPAR β and the proto-oncogene BCL-6,” Molecular and Cellular Biology, vol. 27, no. 23, pp. 8374–8387, 2007. View at Publisher · View at Google Scholar · View at Scopus